Wall Street analyst price targets, ratings consensus & upside potential · Updated Jun 12, 2026
Last 12 months price action with 12-month analyst target path
As of June 16, 2026, Core Laboratories N.V. (CLB) has a Wall Street consensus price target of $25.00, based on estimates from 37 covering analysts. With the stock currently trading at $12.72, this represents a potential upside of +96.5%. The company has a market capitalization of $586M.
Analyst price targets range from a low of $17.00 to a high of $32.00, representing a 60% spread in expectations. The median target of $26.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 16 analysts rating the stock as a Buy or Strong Buy,17 rating it Hold, and 4 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CLB trades at a trailing P/E of 18.7x and forward P/E of 21.2x. Analysts expect EPS to grow -11.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $13.81, with bear and bull scenarios of $8.70 and $18.19 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
Total return calculator · dividends reinvested
Calculate ReturnsDollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side revenue, margins, P/E and 10-year returns vs Exxon Mobil Corporation.
Compare NowQuick answers to the most common questions about buying CLB stock.
The consensus Wall Street price target for CLB is $25, representing 96.5% upside from the current price of $12.72. With 37 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CLB has a consensus rating of "Hold" based on 37 Wall Street analysts. The rating breakdown is mixed, with 17 Hold ratings making up the largest segment. The consensus 12-month price target of $25 implies 96.5% upside from current levels.
CLB trades at a forward P/E of 21.2354x, representing a moderate valuation. With analysts targeting $25 (96.5% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $32 for CLB, while the most conservative target is $17. The consensus of $25 represents the median expectation. Our quantitative valuation model projects a bull case target of $18 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CLB is heavily covered by Wall Street, with 37 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 17 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLB stock forecast based on 37 Wall Street analysts shows a consensus price target of $25, with estimates ranging from $17 (bear case) to $32 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $14, with bear/bull scenarios of $9/$18.
Our quantitative valuation model calculates CLB's fair value at $14 (base case), with a bear case of $9 and bull case of $18. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
CLB trades at a forward P/E ratio of 21.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.7x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CLB, with a "Hold" consensus rating and $25 price target (96.5% upside). 16 of 37 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLB analyst price targets range from $17 to $32, a 60% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $25 consensus represents the middle ground. Our model's $9-$18 range provides an independent fundamental perspective.